Solicitation of Nominations for Membership on the National Vaccine Advisory Committee, 31939-31940 [2013-12598]
Download as PDF
<![CDATA[
Federal Register / Vol. 78, No. 102 / Tuesday, May 28, 2013 / Notices
Islands. (American Samoa does not have a
Program.)
State board: As referenced herein, ‘‘State
board’’ means a group of individuals (usually
appraisers, bankers, consumers, and/or real
estate professionals) appointed by the
Governor or a similarly positioned State
official to assist or oversee State Programs. A
State agency may be headed by a board,
commission or an individual.
Uniform Standards of Professional
Appraisal Practice (USPAP): Refers to
appraisal standards promulgated by the
Appraisal Standards Board of the Appraisal
Foundation establishing minimum
requirements for development and reporting
of appraisals, including real property
appraisal. Title XI requires appraisals
prepared by State certified and licensed
appraisers to be performed in conformance
with USPAP.
*
*
*
*
*
[FR Doc. 2013–12551 Filed 5–24–13; 8:45 am]
BILLING CODE 6210–01–P
Office of the Assistant
Secretary for Health, Office of the
Secretary, Department of Health and
Human Services.
ACTION: Notice.
AGENCY:
BILLING CODE P
FEDERAL RESERVE SYSTEM
Formations of, Acquisitions by, and
Mergers of Bank Holding Companies
mstockstill on DSK4VPTVN1PROD with NOTICES
[FR Doc. 2013–12553 Filed 5–24–13; 8:45 am]
Solicitation of Nominations for
Membership on the National Vaccine
Advisory Committee
Darrin Benhart,
Vice Chairman.
The companies listed in this notice
have applied to the Board for approval,
pursuant to the Bank Holding Company
Act of 1956 (12 U.S.C. 1841 et seq.)
(BHC Act), Regulation Y (12 CFR part
225), and all other applicable statutes
and regulations to become a bank
holding company and/or to acquire the
assets or the ownership of, control of, or
the power to vote shares of a bank or
bank holding company and all of the
banks and nonbanking companies
owned by the bank holding company,
including the companies listed below.
The applications listed below, as well
as other related filings required by the
Board, are available for immediate
inspection at the Federal Reserve Bank
indicated. The applications will also be
available for inspection at the offices of
the Board of Governors. Interested
persons may express their views in
writing on the standards enumerated in
the BHC Act (12 U.S.C. 1842(c)). If the
proposal also involves the acquisition of
a nonbanking company, the review also
includes whether the acquisition of the
nonbanking company complies with the
standards in section 4 of the BHC Act
(12 U.S.C. 1843). Unless otherwise
noted, nonbanking activities will be
conducted throughout the United States.
Unless otherwise noted, comments
regarding each of these applications
must be received at the Reserve Bank
17:46 May 24, 2013
Board of Governors of the Federal Reserve
System, May 22, 2013.
Michael J. Lewandowski,
Assistant Secretary of the Board.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: May 2, 2013.
By the Appraisal Subcommittee.
VerDate Mar<15>2010
indicated or the offices of the Board of
Governors not later than June 21, 2013.
A. Federal Reserve Bank of Dallas (E.
Ann Worthy, Vice President) 2200
North Pearl Street, Dallas, Texas 75201–
2272:
1. Commercial Bancshares, Inc., El
Campo, Texas; to merge with City State
Bancshares, Inc., and thereby indirectly
acquire City State Bank, both in
Palacios, Texas.
Jkt 229001
Authority: 42 U.S.C. 300aa–5, Section 2105
of the Public Health Service (PHS) Act, as
amended. The Committee is governed by the
provisions of Public Law 92–463, as
amended (5 U.S.C. Appendix 2), which sets
forth standards for the formation and use of
advisory committees.
SUMMARY: The National Vaccine
Program Office (NVPO), a program
office within the Office of the Assistant
Secretary for Health, Department of
Health and Human Services (HHS), is
soliciting nominations of qualified
candidates to be considered for
appointment as members to the National
Vaccine Advisory Committee (NVAC).
The activities of this Committee are
governed by the Federal Advisory
Committee Act (FACA). Management
support for the activities of this
Committee is the responsibility of the
NVPO.
Consistent with the National Vaccine
Plan, the Committee advises and makes
recommendations to the Assistant
Secretary for Health in his capacity as
the Director of the National Vaccine
Program, on matters related to the
Program’s responsibilities. Specifically,
the Committee studies and recommends
ways to encourage the availability of an
adequate supply of safe and effective
vaccination products in the United
States; recommends research priorities
and other measures to enhance the
safety and efficacy of vaccines. The
Committee also advises the Assistant
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
31939
Secretary for Health in the
implementation of Sections 2102 and
2103 of the PHS Act; and identifies
annually the most important areas of
government and non-government
cooperation that should be considered
in implementing Sections 2102 and
2103 of the PHS Act.
DATES: All nominations for membership
on the Committee must be received no
later than 5:00 p.m. EDT on June 30,
2013, at the address listed below.
ADDRESSES: All nominations should be
mailed or delivered to: Bruce Gellin,
M.D., M.P.H., Executive Secretary,
NVAC, Office of the Assistant Secretary
for Health, Department of Health and
Human Services, 200 Independence
Avenue SW., Room 715–H, Hubert H.
Humphrey Building, Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Mr.
´
Guillermo Aviles-Mendoza, J.D., LL.M.,
Public Health Advisor, National Vaccine
Program Office, Department of Health
and Human Services, 200 Independence
Avenue SW., Room 739G.4, Hubert H.
Humphrey Building, Washington, DC
20201; (202) 205–2982; nvpo@hhs.gov.
A copy of the Committee charter
which includes the Committee’s
structure and functions as well as a list
of the current membership can be
´
obtained by contacting Mr. AvilesMendoza or by accessing the NVAC
Web site at: www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION: Committee
Function, Qualifications, and
Information Required: As part of an
ongoing effort to enhance deliberations
and discussions with the public on
vaccine and immunization policy,
nominations are being sought for
interested individuals to serve on the
Committee. Individuals selected for
appointment to the Committee will
serve as voting members. The NVAC
consists of 17 voting members. The
Committee is composed of 15 public
members, including the Chair, and two
representative members. Public
members shall be selected from
individuals who are engaged in vaccine
research or the manufacture of vaccines,
or who are physicians, members of
parent organizations concerned with
immunizations, representatives of state
or local health agencies or public health
organizations. Representative members
shall be selected from the vaccine
manufacturing industry who are
engaged in vaccine research or the
manufacture of vaccines. Individuals
selected for appointment to the
Committee can be invited to serve terms
of up to four years.
All NVAC members are authorized to
receive the prescribed per diem
E:\FR\FM\28MYN1.SGM
28MYN1
31940
Federal Register / Vol. 78, No. 102 / Tuesday, May 28, 2013 / Notices
mstockstill on DSK4VPTVN1PROD with NOTICES
allowance and reimbursement for travel
expenses that are incurred to attend
meetings and conduct authorized
Committee-related business, in
accordance with Standard Government
Travel Regulations. Individuals who are
appointed to serve as public members
are authorized also to receive
honorarium for attending Committee
meetings and to carry out other
authorized Committee-related business.
Individuals who are appointed to serve
as representative members for a
particular interest group or industry are
not authorized to receive honorarium
for the performance of these duties.
This announcement is to solicit
nominations of qualified candidates to
fill positions on the NVAC that are
scheduled to be vacated in the public
member category. The positions are
scheduled to be vacated during the
calendar year 2013.
Nominations
In accordance with the charter,
persons nominated for appointment as
members of the NVAC should be among
authorities knowledgeable in areas
related to vaccine safety, vaccine
effectiveness, and vaccine supply.
Nominations should be typewritten. The
following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity); and a statement
that the nominee is willing to serve as
a member of the Committee (2) the
nominator’s name, address and daytime
telephone number, home and/or work
address, telephone number, and email
address; and (3) a current copy of the
nominee’s curriculum vitae.
Individuals can nominate themselves
for consideration of appointment to the
Committee. All nominations must
include the required information.
Incomplete nominations will not be
processed for consideration. The letter
from the nominator and certification of
the nominated individual must bear
original signatures; reproduced copies
of these signatures are not acceptable.
Applications cannot be submitted by
facsimile. The names of Federal
employees should not be nominated for
consideration of appointment to this
Committee. The Department makes
every effort to ensure that the
membership of HHS Federal advisory
committees is fairly balanced in terms of
points of view represented and the
committee’s function. Every effort is
made to ensure that a broad
VerDate Mar<15>2010
17:46 May 24, 2013
Jkt 229001
representation of geographic areas,
gender, ethnic and minority groups, and
the disabled are given consideration for
membership on HHS Federal advisory
committees. Appointment to this
committee shall be made without
discrimination on the basis of age, race,
ethnicity, gender, sexual orientation,
disability, and cultural, religious, or
socioeconomic status.
The Standards of Ethical Conduct for
Employees of the Executive Branch are
applicable to individuals who are
appointed as public members of Federal
advisory committees. Individuals
appointed to serve as public members of
Federal advisory committees are
classified as special Government
employees (SGEs). SGEs are
Government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of NVAC are subject to an
ethics review. The ethics review is
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
Committee. Individuals appointed to
serve as public members of the
Committee will be required to disclose
information regarding financial
holdings, consultancies, and research
grants and/or contracts.
Dated: May 21, 2013.
Bruce Gellin,
Executive Secretary, National Vaccine
Advisory Committee, Deputy Assistant
Secretary for Health, Director, National
Vaccine Program Office.
[FR Doc. 2013–12598 Filed 5–24–13; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60-Day-13–13TD]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–7570 or send
comments to Ron Otten, 1600 Clifton
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
Road, MS–D74, Atlanta, GA 30333 or
send an email to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
‘‘So What? Telling a Compelling
Story’’ Template—New—Office of
Public Health Preparedness and
Response (OPHPR), Centers for Disease
Control and Prevention (CDC).
Background and Brief Description
Background: Stories are difficult to
gather and track; therefore, OPHPR must
use a creative method to collect relevant
stories on the impacts of the Public
Health Emergency Preparedness (PHEP)
grant in state and local health
departments and at the community
level. Several resources and tools exist
within CDC and partner organizations to
share stories but the stories tend to be
dated or already used in another
capacity. OPHPR must be proactive in
leveraging this template to collect new,
timely anecdotes, described as ‘‘leads’’
in the rest of this notice, versus full
stories, in order to describe the current
successes and challenges public health
officials face implementing the PHEP
grant and associated activities.
CDC requests Office of Management
and Budget (OMB) approval to collect
information for three years.
Description: The storytelling template
is a single page, double-sided guide for
storytellers, described as ‘‘sources’’ in
the remainder of this notice. With this
tool, developers intend to dramatically
reduce the burden on respondents and
employees who may otherwise engage
in complete story development with
each new event. In this manner, staff
may tease out pertinent and timely leads
for potential development at a later date
based on the needs of leadership.
Development of a complete story from
this template will occur with a small
percentage of the leads. The text
specifically requested is the source’s
name, telephone number, email address,
organization, job title, the topic of the
E:\FR\FM\28MYN1.SGM
28MYN1
]]>Agencies
[Federal Register Volume 78, Number 102 (Tuesday, May 28, 2013)]
[Notices]
[Pages 31939-31940]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-12598]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the National
Vaccine Advisory Committee
AGENCY: Office of the Assistant Secretary for Health, Office of the
Secretary, Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
Authority: 42 U.S.C. 300aa-5, Section 2105 of the Public Health
Service (PHS) Act, as amended. The Committee is governed by the
provisions of Public Law 92-463, as amended (5 U.S.C. Appendix 2),
which sets forth standards for the formation and use of advisory
committees.
SUMMARY: The National Vaccine Program Office (NVPO), a program office
within the Office of the Assistant Secretary for Health, Department of
Health and Human Services (HHS), is soliciting nominations of qualified
candidates to be considered for appointment as members to the National
Vaccine Advisory Committee (NVAC). The activities of this Committee are
governed by the Federal Advisory Committee Act (FACA). Management
support for the activities of this Committee is the responsibility of
the NVPO.
Consistent with the National Vaccine Plan, the Committee advises
and makes recommendations to the Assistant Secretary for Health in his
capacity as the Director of the National Vaccine Program, on matters
related to the Program's responsibilities. Specifically, the Committee
studies and recommends ways to encourage the availability of an
adequate supply of safe and effective vaccination products in the
United States; recommends research priorities and other measures to
enhance the safety and efficacy of vaccines. The Committee also advises
the Assistant Secretary for Health in the implementation of Sections
2102 and 2103 of the PHS Act; and identifies annually the most
important areas of government and non-government cooperation that
should be considered in implementing Sections 2102 and 2103 of the PHS
Act.
DATES: All nominations for membership on the Committee must be received
no later than 5:00 p.m. EDT on June 30, 2013, at the address listed
below.
ADDRESSES: All nominations should be mailed or delivered to: Bruce
Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of the
Assistant Secretary for Health, Department of Health and Human
Services, 200 Independence Avenue SW., Room 715-H, Hubert H. Humphrey
Building, Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Mr. Guillermo Avil[eacute]s-Mendoza,
J.D., LL.M., Public Health Advisor, National Vaccine Program Office,
Department of Health and Human Services, 200 Independence Avenue SW.,
Room 739G.4, Hubert H. Humphrey Building, Washington, DC 20201; (202)
205-2982; nvpo@hhs.gov.
A copy of the Committee charter which includes the Committee's
structure and functions as well as a list of the current membership can
be obtained by contacting Mr. Avil[eacute]s-Mendoza or by accessing the
NVAC Web site at: www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION: Committee Function, Qualifications, and
Information Required: As part of an ongoing effort to enhance
deliberations and discussions with the public on vaccine and
immunization policy, nominations are being sought for interested
individuals to serve on the Committee. Individuals selected for
appointment to the Committee will serve as voting members. The NVAC
consists of 17 voting members. The Committee is composed of 15 public
members, including the Chair, and two representative members. Public
members shall be selected from individuals who are engaged in vaccine
research or the manufacture of vaccines, or who are physicians, members
of parent organizations concerned with immunizations, representatives
of state or local health agencies or public health organizations.
Representative members shall be selected from the vaccine manufacturing
industry who are engaged in vaccine research or the manufacture of
vaccines. Individuals selected for appointment to the Committee can be
invited to serve terms of up to four years.
All NVAC members are authorized to receive the prescribed per diem
[[Page 31940]]
allowance and reimbursement for travel expenses that are incurred to
attend meetings and conduct authorized Committee-related business, in
accordance with Standard Government Travel Regulations. Individuals who
are appointed to serve as public members are authorized also to receive
honorarium for attending Committee meetings and to carry out other
authorized Committee-related business. Individuals who are appointed to
serve as representative members for a particular interest group or
industry are not authorized to receive honorarium for the performance
of these duties.
This announcement is to solicit nominations of qualified candidates
to fill positions on the NVAC that are scheduled to be vacated in the
public member category. The positions are scheduled to be vacated
during the calendar year 2013.
Nominations
In accordance with the charter, persons nominated for appointment
as members of the NVAC should be among authorities knowledgeable in
areas related to vaccine safety, vaccine effectiveness, and vaccine
supply. Nominations should be typewritten. The following information
should be included in the package of material submitted for each
individual being nominated for consideration: (1) A letter of
nomination that clearly states the name and affiliation of the nominee,
the basis for the nomination (i.e., specific attributes which qualify
the nominee for service in this capacity); and a statement that the
nominee is willing to serve as a member of the Committee (2) the
nominator's name, address and daytime telephone number, home and/or
work address, telephone number, and email address; and (3) a current
copy of the nominee's curriculum vitae.
Individuals can nominate themselves for consideration of
appointment to the Committee. All nominations must include the required
information. Incomplete nominations will not be processed for
consideration. The letter from the nominator and certification of the
nominated individual must bear original signatures; reproduced copies
of these signatures are not acceptable. Applications cannot be
submitted by facsimile. The names of Federal employees should not be
nominated for consideration of appointment to this Committee. The
Department makes every effort to ensure that the membership of HHS
Federal advisory committees is fairly balanced in terms of points of
view represented and the committee's function. Every effort is made to
ensure that a broad representation of geographic areas, gender, ethnic
and minority groups, and the disabled are given consideration for
membership on HHS Federal advisory committees. Appointment to this
committee shall be made without discrimination on the basis of age,
race, ethnicity, gender, sexual orientation, disability, and cultural,
religious, or socioeconomic status.
The Standards of Ethical Conduct for Employees of the Executive
Branch are applicable to individuals who are appointed as public
members of Federal advisory committees. Individuals appointed to serve
as public members of Federal advisory committees are classified as
special Government employees (SGEs). SGEs are Government employees for
purposes of the conflict of interest laws. Therefore, individuals
appointed to serve as public members of NVAC are subject to an ethics
review. The ethics review is conducted to determine if the individual
has any interests and/or activities in the private sector that may
conflict with performance of their official duties as a member of the
Committee. Individuals appointed to serve as public members of the
Committee will be required to disclose information regarding financial
holdings, consultancies, and research grants and/or contracts.
Dated: May 21, 2013.
Bruce Gellin,
Executive Secretary, National Vaccine Advisory Committee, Deputy
Assistant Secretary for Health, Director, National Vaccine Program
Office.
[FR Doc. 2013-12598 Filed 5-24-13; 8:45 am]
BILLING CODE 4150-28-P
